dr. chen on the impact of the pivotal impower133 trial on sclc
Published 4 years ago • 420 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
7:20
small-cell lung cancer: the impower133 and caspian trials
-
6:33
a win for small–cell lung cancer: impower 133
-
1:22
dr. horn on updated data from impower133 in small cell lung cancer
-
1:50
small cell lung cancer: interpreting data from impower133
-
3:08
impower133 and caspian trials for extensive stage sclc
-
5:06
impower133 in sclc
-
1:59
dr. lai on the results of the caspian trial in small cell lung cancer
-
8:11
first-line immunotherapy: impower133 regimen
-
1:57
dr. moghanaki on the impact of the pacific trial on nsclc treatment
-
1:33
dr. chaft on the rise of immunotherapy in lung cancer
-
1:44
dr. liu on the checkmate-032 trial in sclc
-
1:33
dr. chaft on the emergence of immunotherapy in stage iv lung cancer
-
5:22
chemoimmunotherapy for es sclc: impower133 trial
-
1:02
dr. rudin on the design of the keynote-604 trial in es-sclc
-
1:24:26
assessing the impact of therapeutic advances in sclc
-
1:37
dr. ready on the benefit of pd-l1 inhibition in sclc
-
2:35
atezo maintenance therapy improves survival in the impower133 trial of es-sclc
-
1:50
impower133: atezolizumab, carboplatin plus etoposide for sclc
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc